CorMedix (CRMD) PT Lowered to $21 at RBC Capital, 'we would be buyers'
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev lowered the price target on CorMedix (NASDAQ: CRMD) to $21.00 (from $23.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
